Key facts
- Notable investors include NewSpring Capital, North Haven Capital, Bluwave Capital, Brooke Private Equity Associates Management, SharpVue Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Curalta Foot & Ankle
- ·The full record, as it builds
Funding rounds
No funding rounds for Curalta Foot & Ankle are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Curalta Foot & Ankle
Provider of podiatry healthcare services intended to help people take better care of their feet. The company offers bunion, wart and hammertoe treatment, diabetic foot care, orthotics, heel pain and wound care services, ensuring patients treat their own foot and ankle health efficiently.
- Sector
- Healthcare
- HQ
- Rochelle Park, NJ, United States
- Founded
- 2021
- Employees
- 125
- Website
- curalta.com/
- Ownership
- Privately Held (backing)
Curalta Foot & Ankle doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Curalta Foot & Ankle shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Curalta Foot & Ankle in its N-PORT filings yet. We sweep new filings monthly.